Type 2 Diabetes

Study shows that diabetes duration (ie, how long they've had the disease) is linked with an increased risk of thromboembolism in patients with atrial fibrillation, but not with an increased risk of anticoagulation-related bleeding.

T2DM patients who underwent surgery experienced decreased use of diabetes medications, if not partial or complete disease remission.

Patients diagnosed with diabetes may be able to blame the food their ancestors ate for their condition as easily as they can blame their own eating habits, according to a recent study.

The reaction to an editorial claiming that exercise alone will not help patients lose weight is illustrative of the biases held by certain groups and underscores the need for greater education and awareness of the science of weight loss for patients and clinicians.

A recent study out of Finland found that men who ate chicken eggs on a regular basis had a lower risk of developing type 2 diabetes mellitus. Like a number of other recent studies this article stands in contrast to what was once the conventional wisdom: that eating foods high in cholesterol would increase your risk of heart disease and its risk factors.

The following studies highlight recent findings in fracture screening, fracture healing, and possible fracture prevention in T2DM patients.

The ‘cup of joe' that 54% of American adults consume every day, according to a survey, has a surprising effect on the risk of disease.

There are pros and cons to using SGLT2 inhibitors in the elderly. Are you familiar with both? Find out with 7 quick multiple choice questions.

Not only have researchers uncovered a key factor that drives neuropathic pain, they have also identified a strategy to reverse it.

The benefits of weight loss for patients undergoing gastric bypass surgery have been well established, but now researchers are focusing their attention on the procedure's benefits for patients with type 2 diabetes mellitus.

This slideshow presents several tips to keep in mind once ICD-10 goes live.

A large phase IIIb study showed no increased risk for cardiovascular problems with GLP-1 receptor agonist lixisenatide.

A recent study assessed patients with diabetes for the effects of perceived racial discrimination encountered during care, focusing on treatment outcomes such as glycemic control, blood pressure, and LDL cholesterol levels.

The practice of individualized medicine took another step forward recently when researchers at the University of Pennsylvania found that a patient's genetic variations can determine how they respond to anti-diabetic drugs.

GLP-1 receptor agonists may help patients with type 2 diabetes to lose weight by altering the way their brains respond to food.

The Food and Drug Administration (FDA) issued a formal communication warning about the risk of acidosis with the use of SGLT2 inhibitors.

Researchers from the University of California-Santa Barbara recently announced they have created an implantable "artificial pancreas" that could potentially eliminate the need for insulin injections and pumps for treating type 1 diabetes.

As more research is done the more it appears brown fat will play a key role in the future treatment of diabetes.

Data from two observational registries indicated that long-term testosterone replacement therapy in diabetic men was associated not only with better sexual function and weight loss, but also significant reductions in blood sugar.

Patients with diabetes may already be at increased risk for genital mycotic infections. We look at the likelihood of infection with SGLT2 inhibitors.

Patients with diabetes face a variety of health challenges as a result of their condition, including diabetic blindness. A team of researchers at the University of Virginia is working with stem cells to try and prevent loss of vision in these patients due to diabetic retinopathy.

Public health ad campaigns are not so prevalent as they were a few decades ago. Primary care doctors in South Carolina have taken over where Madison Avenue left off. Cardiovascular disease has since fallen.

As the US population ages, better primary care is essential to keeping costs down. But so far, the new focus on that specialty has not resulted in adequate reimbursement, said Brent Egan, MD, speaking June 27 at a meeting of primary care physicians in Charleston, SC. He believes that will change.

The "sweet spot" where blood pressure control reduces cardiovascular risk without undue side effects may actually be a little higher than traditionally recommended for people with diabetes between ages 60 and 85.

Chronic exposure to superantigens, such as Staphylococcus aureus, may play a role in impaired glucose metabolism and the development of type 2 diabetes in the overweight and obese.

Diabetes can be a difficult condition for patients to manage no matter how old they are, but it can be especially difficult during adolescence. A recent study looked at whether taking care of a water-loving friend could actually help young patients with diabetes take better care of themselves.

Treatment for patients who are obese or overweight have seen significant improvements in treatment options over the past decade, but there is still much ore work to be done.

Lipid management is a complex issue. Peter Jones, MD, a Houston, TX, internist who specializes in lipidology, offers advice to primary care physicians trying to sort out competing treatment guidelines.

We present tips for your diabetic patients to remember while traveling and dealing with heat and humidity.

We present 3 studies that show the importance of managing cardiovascular risks in your diabetic patients.